Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Feb 20, 2025. A box jumps to the paragraph as filed, below.
3 paragraphs in Risk Factors of the 10-K filed Feb 20, 2026 with nothing like them in the 10-K filed Feb 20, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
Compared with the Risk Factors in the latest 10-K of the other 31 Consumer staples companies: a paragraph with at least half its words the same at another company is called similar, and the companies are listed under it. A paragraph most of them have is marked boilerplate. No line means no other company has one like it. This counts text; it does not say how serious a risk is.
risks and/or our ability to hire and retain the best talent will be diminished, which could have an adverse impact on our overall business.
document requests, the assessment of damages, the imposition of penalties, the suspension of production or distribution, costly changes to equipment or processes due to required corrective action, or the cessation or interruption of operations at our or our bottling partners’ facilities, as well as damage to our or our bottling partners’ image and reputation, all of which could harm our or our bottling partners’ profitability.
in scrutiny, reputational risk, product boycotts, lawsuits or market access restrictions from these parties regarding our sustainability policies, practices or initiatives.
New in the latest 10-Q
14 paragraphs in the 10-Q filed Oct 28, 2026 with nothing like them in the 10-Q filed Jul 29, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
The Company did not reclassify any gains or losses during the three and nine months ended October 2, 2026, or the three and nine months ended September 26, 2025.
Read in the 10-Q
Three Months Ended October 2, 2026 Before-Tax Amount Income Tax After-Tax Amount
Read in the 10-Q
Gains (losses) on intra-entity transactions that are of a long-term investment nature (387) — (387)
Read in the 10-Q
Net change in unrealized gains (losses) on available-for-sale debt securities2 $ (3) $ (4) $ (7)
Read in the 10-Q
1 In July 2025, we sold a 40 % noncontrolling interest in our bottling operations in India to a local partner for approximately $ 1.3 billion, which, net of direct costs, resulted in an increase to total equity of $ 1.1 billion. As a result, 40 % of the subsidiary’s equity was allocated to the noncontrolling interest and the remaining amount was recorded in capital surplus. Additionally, $ 226 million of foreign currency translation adjustments included in AOCI were allocated to the noncontrolling interest.
Read in the 10-Q
1 In July 2025, we sold a 40 % noncontrolling interest in our bottling operations in India to a local partner for approximately $ 1.3 billion, which, net of direct costs, resulted in an increase to total equity of $ 1.1 billion. As a result, 40 % of the subsidiary’s equity was allocated to the noncontrolling interest and the remaining amount was recorded in capital surplus. Additionally, $ 226 million of foreign currency translation adjustments included in AOCI were allocated to the noncontrolling interest.
Read in the 10-Q
Benefit Plans Three Months Ended October 2, September 26, October 2, September 26,
Read in the 10-Q
2 The settlement loss is related to the buy-out of a non-U.S. defined benefit plan.
Read in the 10-Q
3 The special termination benefits represent benefit uplifts provided to plan participants included in the buy-out.
Read in the 10-Q
Benefit Plans Nine Months Ended October 2, September 26, October 2, September 26,
Read in the 10-Q
2 The settlement loss is related to the buy-out of a non-U.S. defined benefit plan.
Read in the 10-Q
4 The special termination benefits represent benefit uplifts provided to plan participants included in the 2026 buy-out and the 2025 buy-in.
Read in the 10-Q
Henrique Braun, Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement on August 28, 2026 for the potential exercise of vested stock options and the associated sale of up to 136,968 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is August 28, 2028, or such earlier date upon which all transactions are completed. His trading plan was adopted during an open trading window.
Read in the 10-Q
10.2 Deferred Cash Agreement between the Company and Rob Gehring, dated September 8, 2026.
Read in the 10-Q
Item 1A of the 10-Q filed Oct 28, 2026 against Item 1A of the 10-K filed Feb 20, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted).
Text on the page, not a score; each links to the filing at sec.gov.
Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.
10-K change: what was reworded or cut, section by section.
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KO/export.csv") into a cell.
